Skip to main content

Advertisement

SpringerLink
Log in

Reply to Dereke, J., Hillman, M. “The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review” Acta Diabetol (2017) 54:885. https://doi.org/10.1007/s00592-017-1026-6

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dereke J, Hillman M (2017) The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review. Acta Diabetol 54(9):885–886. https://doi.org/10.1007/s00592-017-1026-6

    Article  PubMed  CAS  Google Scholar 

  2. Ning H et al (2016) Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus. Acta Diabetol 53(6):891–898

    Article  PubMed  CAS  Google Scholar 

  3. Kralisch S et al (2009) Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 160(1):33–38

    Article  PubMed  CAS  Google Scholar 

  4. Ortega-Senovilla H et al (2011) Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 34(9):2061–2066

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Li YY et al (2015) Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus. Med Sci Monit 21:426–431

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250012, Shandong, China

    Hui Ning & Xingbo Zhao

  2. Department of Obstetrics and Gynaecology, Qingdao Municipal Hospital, Qingdao, 266000, Shandong, China

    Hui Ning, Hong Tao & Zhanping Weng

Authors
  1. Hui Ning
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hong Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhanping Weng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xingbo Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xingbo Zhao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Standard

This article does not contain any studies with human or animal subjects performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Additional information

Managed by Massimo Porta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ning, H., Tao, H., Weng, Z. et al. Reply to Dereke, J., Hillman, M. “The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review” Acta Diabetol (2017) 54:885. https://doi.org/10.1007/s00592-017-1026-6. Acta Diabetol 55, 987–988 (2018). https://doi.org/10.1007/s00592-018-1178-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1178-z

Search

Navigation